| ［1］ |
史艳侠, 邢镨元, 张俊, 等. 中国肿瘤化疗相关性血小板减少症专家诊疗共识(2019版)[J]. 中国肿瘤临床, 2019, 46(18): 923–929.
|
| ［2］ |
蒋怡帆, 龚建平. 吉西他滨联合替吉奥与吉西他滨单药化疗治疗晚期胰腺癌比较的Meta分析[J]. 国际肿瘤学杂志, 2014, 41(3): 233–237.
|
| ［3］ |
刘悦泽, 张太平, 赵玉沛. 日本胰腺学会《胰腺癌临床实践指南(2022年版)》更新解读[J]. 中国实用外科杂志, 2023, 43(7): 772–776.
|
| ［4］ |
中华人民共和国国家卫生健康委员会医政医管局. 胰腺癌诊疗指南(2022年版)[J]. 中华消化外科杂志, 2022, 21(9): 1117–1136.
|
| ［5］ |
中华医学会外科学分会胰腺外科学组. 中国胰腺癌诊治指南(2021)[J]. 中华外科杂志, 2021, 59(7): 561–577.
|
| ［6］ |
陈佳浩, 姜翀弋. 2023年第2版《NCCN胰腺癌临床实践指南》更新解读[J]. 外科理论与实践, 2024, 29(1): 10–13.
|
| ［7］ |
白睿, 孙备. NCCN胰腺癌临床实践指南(2023. V2版)更新解读[J]. 中国实用外科杂志, 2024, 44(1): 85–88.
|
| ［8］ |
Mizusawa J, Morizane C, Okusaka T, et al. Randomized phase Ⅲ study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT)[J]. Jpn J Clin Oncol, 2016, 46(4): 385–388.
|
| ［9］ |
Weycker D, Hatfield M, Grossman A, et al. Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice[J]. BMC Cancer, 2019, 19(1): 151.
|
| ［10］ |
Lu W, Bakhtary S, Oliver L, et al. How do we direct a transfusion service/blood bank with limited laboratory staff[J]. Transfusion, 2023, 63(11): 2023–2031.
|
| ［11］ |
Kaushansky K. The thrombocytopenia of cancer. Prospects for effective cytokine therapy[J]. Hematol Oncol Clin North Am, 1996, 10(2): 431–455.
|
| ［12］ |
吕蓉, 朱发明, 叶欣, 等. 免疫性血小板输注无效的判定及临床实践专家共识[J]. 临床输血与检验, 2022, 24(3): 273–278.
|
| ［13］ |
Chang J. Chemotherapy dose reduction and delay in clinical practice. evaluating the risk to patient outcome in adjuvant chemotherapy for breast cancer[J]. Eur J Cancer, 2000, 36 Suppl 1: S11-S14.
|
| ［14］ |
Apelseth TO, Hervig T, Bruserud O. Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia[J]. Blood Rev, 2011, 25(3): 113–122.
|
| ［15］ |
Weycker D, Hatfield M, Hanau A, et al. Risk and cost of chemotherapy-induced thrombocytopenia (CIT) in US clinical practice[J]. J Clin Oncol, 2018, 36(15_suppl): e18911.
|
| ［16］ |
徐瑞华, 石远凯, 冯继锋, 等. 中国肿瘤化疗相关性血小板减少症专家诊疗共识(2019版)[J/OL]. 中国医学前沿杂志(电子版), 2020, 12(1): 51–58.
|